Thoratec

Thoratec is a global leader in the development and manufacturing of mechanical circulatory support systems for patients with advanced heart failure. The company's flagship products include the HeartMate II and HeartMate 3 left ventricular assist devices (LVADs), which are used for both bridge-to-transplant and destination therapy. Thoratec also offers acute support solutions such as the CentriMag and PediMag systems, which provide temporary support for patients in cardiac shock. In 2015, the company was acquired by St. Jude Medical for approximately $3.4 billion, and it is now part of Abbott Laboratories. Its technologies remain the gold standard for long-term mechanical heart support, significantly improving survival and quality of life for patients with end-stage heart disease.